City Insurance PLC. (DSE:CITYGENINS)
Bangladesh · Delayed Price · Currency is BDT 123.70
-1.20 (-0.96%)
At close: Aug 13, 2026
City Insurance PLC. Income Statement
Financials in millions BDT. Fiscal year is January - December.
Millions BDT. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 536.66 | 607.48 | 583.93 | 516.49 | 567.91 | 483.41 |
Total Interest & Dividend Income | 301.93 | 237.58 | 118.54 | 94.09 | 66.77 | 63.58 |
Gain (Loss) on Sale of Investments | 0.67 | 0.67 | 23.62 | 4.42 | 13.28 | 14.41 |
Other Revenue | 68.81 | 73.23 | 84.45 | 58.94 | 66.87 | 55.15 |
| 908.07 | 918.97 | 810.54 | 673.93 | 714.83 | 616.54 | |
Revenue Growth | 4.28% | 13.38% | 20.27% | -5.72% | 15.94% | 40.02% |
Policy Benefits | 118.29 | 146.57 | 102.59 | 19.54 | 91.08 | 179.64 |
Policy Acquisition & Underwriting Costs | 64.45 | 140.62 | 154.74 | 121.19 | 161.72 | 55.37 |
Depreciation & Amortization | 4.8 | 4.8 | 4.98 | 7.89 | 6.61 | 7.19 |
Selling, General & Administrative | 233.94 | 259.12 | 250.16 | 222.2 | 241.33 | 208.62 |
Total Operating Expenses | 421.49 | 551.12 | 512.47 | 370.81 | 500.74 | 450.81 |
Operating Income | 486.57 | 367.85 | 298.08 | 303.12 | 214.09 | 165.73 |
Interest Expense | - | - | - | - | - | -1.22 |
Other Non Operating Income (Expenses) | -1.23 | -1.23 | -2.5 | -1.69 | -1.39 | -0.87 |
EBT Excluding Unusual Items | 485.34 | 366.62 | 295.58 | 301.44 | 212.7 | 163.63 |
Gain (Loss) on Sale of Assets | 0.66 | 0.66 | 0.53 | -0.01 | 0.91 | - |
Asset Writedown | -1 | -1 | -1 | -1 | -1 | -1.02 |
Pretax Income | 485 | 366.28 | 295.11 | 300.42 | 212.61 | 162.61 |
Income Tax Expense | 179.93 | 134.51 | 85.43 | 94.79 | 59.03 | 47.89 |
Net Income | 305.07 | 231.76 | 209.68 | 205.64 | 153.58 | 114.72 |
Net Income to Common | 305.07 | 231.76 | 209.68 | 205.64 | 153.58 | 114.72 |
Net Income Growth | 51.07% | 10.53% | 1.97% | 33.90% | 33.88% | -4.99% |
Shares Outstanding (Basic) | 68 | 68 | 68 | 68 | 68 | 68 |
Shares Outstanding (Diluted) | 68 | 68 | 68 | 68 | 68 | 68 |
Shares Change | 0.26% | - | - | - | - | - |
EPS (Basic) | 4.47 | 3.40 | 3.08 | 3.02 | 2.25 | 1.68 |
EPS (Diluted) | 4.47 | 3.40 | 3.08 | 3.02 | 2.25 | 1.68 |
EPS Growth | 50.67% | 10.53% | 1.97% | 33.90% | 33.88% | -4.99% |
Free Cash Flow | 291.9 | 292.78 | 165.02 | 169.02 | 370.87 | 167.32 |
Free Cash Flow Per Share | 4.28 | 4.29 | 2.42 | 2.48 | 5.44 | 2.46 |
Dividend Per Share | - | 1.000 | 1.000 | 1.200 | 1.050 | 1.000 |
Dividend Growth | - | 0% | -16.67% | 14.29% | 5.00% | 0% |
Operating Margin | 53.58% | 40.03% | 36.78% | 44.98% | 29.95% | 26.88% |
Profit Margin | 33.60% | 25.22% | 25.87% | 30.51% | 21.49% | 18.61% |
Free Cash Flow Margin | 32.15% | 31.86% | 20.36% | 25.08% | 51.88% | 27.14% |
EBITDA | 491.07 | 372.4 | 302.74 | 310.74 | 220.47 | 172.63 |
EBITDA Margin | 54.08% | 40.52% | 37.35% | 46.11% | 30.84% | 28.00% |
D&A For EBITDA | 4.49 | 4.55 | 4.66 | 7.62 | 6.38 | 6.9 |
EBIT | 486.57 | 367.85 | 298.08 | 303.12 | 214.09 | 165.73 |
EBIT Margin | 53.58% | 40.03% | 36.78% | 44.98% | 29.95% | 26.88% |
Effective Tax Rate | 37.10% | 36.73% | 28.95% | 31.55% | 27.76% | 29.45% |